Oliver Wyman has assessed that an initiative to reduce your external spend could have an EBITDA impact ranging from 150 basis points to more than 600 basis points, depending on which industry....
Browse the SRC
Many CFOs share the same issue: 4 out 5 are facing difficulties reconciling the savings generated by initiatives on external spend and the financial impact on the P&L. Why? It just appears too...
The days of rapid growth and high margin levels are no more for the pharmaceutical industry. In order to continue delivering high and attractive profitability ratios, the industry is now faced...